Drug and Device Law

Despite all the notices we sent out, many of you on the old Google email list haven't yet signed

As you've probably gathered from our posts this week, the Drug and Device Law blog is going on a

Today's guest post is by Adam M. Masin, a partner at Shipman & Goodwin LLP. It's

One of the greatest spectacles on earth is the annual migration of wildebeest, zebras, and antelope

Hardly a week goes by without our blogging about accusations of off label promotion. This week is no

Today's guest post is courtesy of Reed Smith's Lindsey Harteis. She's been following the

This post comes from the Cozen O'Connor side of the blog. Last week, the New York Appellate

In terms of the legal gyrations plaintiffs try to avoid preemption, we've already expressed our

Another guest post today, this one by Reed Smith's Matt Jacobson on the draft guidance document

Over the years we have completed many written evaluations of young associates, and the first category

This post is from the non-Reed Smith side of the blog. In Glennen v. Allergan, Inc., -- Cal. Rptr.3d

This post comes from the Cozen O'Connor side of the blog. Drug and device lawsuits fling open the

This post is from the non-Reed Smith side of the blog. We found it strange that last month's

We generally file motions to dismiss for forum non conveniens under one of two circumstances. Most

In Hawaii, from whence today's case comes, tourists are encouraged to try poi, mashed up taro

Sometimes it takes us a while to catch on to things. This is more than a little embarrassing for a

In Witt v. Stryker Corp., 2016 WL 1583816 (11 th Cir. Apr. 20, 2016), a Daubert decision in a Stryker

Can you get sued over a picture of a banana? It seems the answer might depend on where you live and

We talk a lot about PMA preemption on this blog. And why shouldn't we. It's probably been the

The plaintiff in Frere v. Medtronic, Inc., 2016 WL 1533524 (CD Cal. April 6, 2014), was an 80 year-

For years we've advocated about ediscovery for defendants – consisting mostly of material

As we've discussed previously, and as the legal profession is by now well aware, the discovery

According to Black's Law Dictionary, “a fortiori” is legal Latin meaning: By even greater force

We aren't going to mince words today. We don't like Christiansen v. Wright Medical Technology

In third party payor litigation over prescription medical products, we have often marveled at the

This week, as Drug and Device Law Jews, we are preparing for Passover, which, like most Jewish

From our prior personal jurisdiction posts concerning Daimler AG v. Bauman, 134 S. Ct. 746 (2014),

In drug and device litigation, product identification can be a significant issue. Many of us have

How much is “enough?” Will we have enough money to retire someday? Did the Drug and Device Law

It's only been one month since we posted about the disappointing decision in the Xarelto MDL